SBC Medical Group (SBC)
SBC Medical Statistics
Share Statistics
SBC Medical has 103.02M shares outstanding. The number of shares has increased by null% in one year.
Shares Outstanding | 103.02M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | n/a |
Owned by Institutions (%) | n/a |
Shares Floating | - |
Failed to Deliver (FTD) Shares | 73 |
FTD / Avg. Volume | 0.24% |
Short Selling Information
The latest short interest is 31.74K, so 0.03% of the outstanding shares have been sold short.
Short Interest | 31.74K |
Short % of Shares Out | 0.03% |
Short % of Float | 2.03% |
Short Ratio (days to cover) | 0.62 |
Valuation Ratios
The PE ratio is undefined and the forward PE ratio is 7.28. SBC Medical's PEG ratio is undefined.
PE Ratio | undefined |
Forward PE | 7.28 |
PS Ratio | 5.62 |
Forward PS | 1.3 |
PB Ratio | 7.65 |
P/FCF Ratio | undefined |
PEG Ratio | undefined |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for SBC Medical Group.
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.79, with a Debt / Equity ratio of undefined.
Current Ratio | 1.79 |
Quick Ratio | 1.76 |
Debt / Equity | undefined |
Total Debt / Capitalization | 13.86 |
Cash Flow / Debt | 2.21 |
Interest Coverage | undefined |
Financial Efficiency
Return on equity (ROE) is 0.28% and return on capital (ROIC) is 22.22%.
Return on Equity (ROE) | 0.28% |
Return on Assets (ROA) | 0.15% |
Return on Capital (ROIC) | 22.22% |
Revenue Per Employee | $224,267 |
Profits Per Employee | $45,619.97 |
Employee Count | 863 |
Asset Turnover | 0.75 |
Inventory Turnover | 18.19 |
Taxes
Income Tax | 35.02M |
Effective Tax Rate | 0.48 |
Stock Price Statistics
The stock price has increased by -75.39% in the last 52 weeks. The beta is 0.39, so SBC Medical's price volatility has been higher than the market average.
Beta | 0.39 |
52-Week Price Change | -75.39% |
50-Day Moving Average | 4.38 |
200-Day Moving Average | 8.12 |
Relative Strength Index (RSI) | 34.11 |
Average Volume (20 Days) | 31.05K |
Income Statement
In the last 12 months, SBC Medical had revenue of 193.54M and earned 39.37M in profits. Earnings per share was 0.39.
Revenue | 193.54M |
Gross Profit | 137.3M |
Operating Income | 70.66M |
Net Income | 39.37M |
EBITDA | 85.87M |
EBIT | 70.66M |
Earnings Per Share (EPS) | 0.39 |
Balance Sheet
The company has 103.02M in cash and 22.87M in debt, giving a net cash position of 80.16M.
Cash & Cash Equivalents | 103.02M |
Total Debt | 22.87M |
Net Cash | 80.16M |
Retained Earnings | 142.85M |
Total Assets | 296.48M |
Working Capital | 129.68M |
Cash Flow
In the last 12 months, operating cash flow was 50.64M and capital expenditures -11.21M, giving a free cash flow of 39.44M.
Operating Cash Flow | 50.64M |
Capital Expenditures | -11.21M |
Free Cash Flow | 39.44M |
FCF Per Share | 0.39 |
Margins
Gross margin is 70.94%, with operating and profit margins of 36.51% and 20.34%.
Gross Margin | 70.94% |
Operating Margin | 36.51% |
Pretax Margin | 38.02% |
Profit Margin | 20.34% |
EBITDA Margin | 44.37% |
EBIT Margin | 36.51% |
FCF Margin | 20.38% |
Dividends & Yields
SBC does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Payout Ratio | n/a |
Earnings Yield | 12.38% |
FCF Yield | 12.15% |
Analyst Forecast
Currently there are no analyst rating for SBC.
Price Target | n/a |
Price Target Difference | n/a |
Analyst Consensus | n/a |
Analyst Count | n/a |
Scores
Altman Z-Score | 5.2 |
Piotroski F-Score | 8 |